FAVORABLE SAFETY PROFILE OF TIRBANIBULIN 1% OINTMENT FOR ACTINIC KERATOSIS: POOLED RESULTS FROM TWO PHASE 3 STUDIES

被引：0
|
作者：
Du Jardin, Kristian Gaarn [1 ]
Schlesinger, Todd [2 ]
Bhatia, Neal [3 ]
Berman, Brian [4 ]
Padulles, Laura [5 ]
Cutler, David [6 ]
Lebwohl, Mark [7 ]
机构：
[1] Almirall, Global Med Affairs, Barcelona, Spain
[2] Clin Res Ctr Carolinas, Charleston, SC USA
[3] Therapeut Clin Res, San Diego, CA USA
[4] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA
[5] Almirall, Barcelona, Spain
[6] Athenex Inc, Buffalo, NY USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2022年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PW15
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [41] THE IMPACT OF LEMBOREXANT TREATMENT ON INSOMNIA DISEASE SEVERITY: RESULTS FROM A POOLED ANALYSIS OF TWO PHASE 3 STUDIES
    Roth, T.
    Rosenberg, R.
    Yardley, J.
    Kumar, D.
    Pinner, K.
    Perdomo, C.
    Moline, M.
    SLEEP MEDICINE, 2019, 64 : S325 - S326
  • [42] Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121
  • [43] Cardiac safety profile of ozanimod in pooled phase 3 studies in relapsing multiple sclerosis (SUNBEAM and RADIANCE)
    Cree, B. A. C.
    Comi, G.
    Mendzelevski, B.
    Skolnick, B. E.
    Agafonova, N.
    Ding, N.
    Minton, N.
    Sheffield, J. K.
    Kleiman, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 266 - 267
  • [44] Safety and tolerability of fentanyl sublingual spray during the titration phase of two phase 3 clinical trials: results from pooled data
    Rauck, R.
    Stearns, L.
    Forman, N.
    Parikh, N.
    Dillaha, L.
    JOURNAL OF PAIN, 2014, 15 (04): : S67 - S67
  • [45] Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies
    Andersen, Y. M. F.
    Egeberg, A.
    Balslev, E.
    Jorgensen, C. L. T.
    Szecsi, P. B.
    Stender, S.
    Kaae, J.
    Linneberg, A.
    Gislason, G.
    Skov, L.
    Elias, P. M.
    Thyssen, J. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (06) : 1038 - 1043
  • [46] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Valenzuela, C.
    Keystone, F.
    Winthrop, K.
    Genovese, H.
    Combe, B.
    Tanaka, Y.
    Kivitz, A.
    Matzkiess, F.
    Bartok, B.
    Ye, L.
    Guo, Y.
    Sundy, J.
    Tasset, C.
    Westhovens, R.
    Rigby, W.
    Burmester, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 127 - 127
  • [47] Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
    Winthrop, Kevin
    Genovese, Mark
    Combe, Bernard
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Keystone, Edward
    Westhovens, Rene
    Rigby, William F. C.
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bartok, Beatrix
    Winthrop, Kevin L.
    Genovese, Mark
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Ye, Lei
    Guo, Ying
    Tasset, Chantal T.
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    Walker, David R.
    GASTROENTEROLOGY, 2020, 158 (06) : S679 - S679
  • [49] Pooled Efficacy and Safety from Phase 3 Controlled Studies of Tanezumab in Patients with Osteoarthritis
    Tive, Leslie
    Radin, David
    Bello, Alfonso
    Ha Nguyen
    Brown, Mark T.
    West, Christine R.
    Verburg, Kenneth M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
    Keystone, Edward
    Winthrop, Kevin
    Genovese, Mark
    Combe, Bernard
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lie
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1108 - 1108
12345